TScan Therapeutics Announces Upcoming Trial In Progress Poster Presentation At The 2023 American Society Of Clinical Oncology Annual Meeting On June 3, 2023; 8:00 am – 11:00 am CDT
Portfolio Pulse from Happy Mohamed
TScan Therapeutics (NASDAQ:TCRX) will present a Trial in Progress poster at the 2023 American Society of Clinical Oncology Annual Meeting on June 3, 2023, focusing on T-Plex, a multiplexed, enhanced T cell receptor engineered T cell therapy for solid tumors.

June 01, 2023 | 8:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TScan Therapeutics' presentation at the 2023 ASCO Annual Meeting may generate interest in the company's T-Plex therapy and potentially impact its stock price.
The presentation of T-Plex trial progress at the prestigious ASCO Annual Meeting may generate interest in TScan Therapeutics' TCR-engineered T cell therapy for solid tumors. This increased attention could lead to a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100